Monsanto’s smear merchant, the Genetic Literacy Project, is now Bayer’s bully
By Jonathan Matthews,
GMWatch
| 08. 31. 2022
Recently the Genetic Literacy Project has been heavily targeting critics of the herbicide Roundup, now owned by Bayer, with a barrage of articles, podcasts, and tweets, in which the controversial University of Florida scientist Kevin Folta has been much to the fore.
It all started when the Guardian published a piece by the award-winning journalist Carey Gillam on a CDC study showing the prevalence in urine samples in the US of Roundup’s controversial active ingredient glyphosate, which has been linked to cancer.
Kevin Folta led the charge for the GLP with a piece that labelled the Guardian article the latest example of “yellow journalism” (i.e. lurid, sensationalist reporting), not to mention “deceptive journalism”, by “scientifically illiterate journalists”. Folta then gave over a further three paragraphs to attacking Gillam personally and outlining his version of her “ethically questionable history”. This somehow failed to mention that, among other things, she won a Society of Environmental Journalists’ book award or that her former colleagues at Reuters say she is “an exceptional journalist” who produces “impeccably reported” stories.
“Slimeball tactics”
The GLP, which has...
Related Articles
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Sarah Norcross, Sandy Starr, Amanda Cooney, and Anneliese Burton, BioNews | 07.06.2026
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...